Answer
Tafamidis (Vyndaqel 61 mg soft capsules) is contraindicated in patients with hypersensitivity to tafamidis or any of the excipients listed in section 6.1 of its product information.
Sources for this answer
- Vyndaqel 61 mg soft capsulesPfizer Limited · emc · SmPC §4.3 Contraindications · Version 7Document updated
Sources checked